Granite Shares Advisors LLC Amgen Inc Transaction History

Granite Shares Advisors LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	SELL	$214.27 - $253.37 $11,142 - $13,175	-52 Reduced 3.21%	1,567 $347,000
Q1 2023 Apr 24, 2023	SELL	$225.79 - $275.2 $4,290 - $5,228	-19 Reduced 1.16%	1,619 $391,000
Q4 2022 Jan 26, 2023	SELL	$229.03 - $291.01 $65,502 - $83,228	-286 Reduced 14.86%	1,638 $0
Q3 2022 Oct 14, 2022	SELL	$224.46 - $253.15 $44,892 - $50,630	-200 Reduced 9.42%	1,924 $433,000
Q2 2022 Jul 22, 2022	SELL	$230.71 - $256.74 $98,743 - $109,884	-428 Reduced 16.77%	2,124 $516,000
Q1 2022 May 06, 2022	SELL	$219.27 - $242.57 $44,073 - $48,756	-201 Reduced 7.3%	2,552 $617,000
Q4 2021 Feb 08, 2022	BUY	$198.88 - $227.6 $547,516 - $626,582	2,753 New	2,753 $619,000

3,122

410M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Granite Shares Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Granite Shares Advisors LLC with notifications on news.